Medicare Part B Drug Reimbursement: Why Change A Market-Driven System That Works Well at Controlling

The Joint Select Committee on Deficit Reduction must focus on mandatory spending programs to be successful. Unfortunately, proposals to alter Medicare Part B drug reimbursement place a successful program and the patients it supports at risk and thus are not sound and sustainable reform policies that support overall debt reduction.


Click here to read the rest of the report.